Nav: Home

H3N2 viruses mutate during vaccine production but new tech could fix it

April 29, 2019

MADISON, Wis. -- In late March 2019, the World Health Organization and a vaccine advisory committee of the Food and Drug Administration selected the final influenza strains to include in the vaccines produced for the next flu season. These include H1N1, influenza B, and H3N2 viruses.

The goal is to find the best match between the vaccine and the influenza strains most likely to be circulating in the environment, particularly because flu viruses frequently mutate and can differ across time and from region to region. One common problem, however, is that the viruses chosen for vaccines often mutate in the process of production, creating mismatches between seasonal flu viruses and the vaccine in any given flu season. This has been a particular problem with H3N2 viruses.

But a new technology developed by the University of Wisconsin¬-Madison's Yoshihiro Kawaoka may make H3N2 vaccine development a bit easier. In Nature Microbiology today [April 29, 2019], Kawaoka and his team describe a new cell line that enables better growth of H3N2 for vaccine use. The virus is also far less likely to mutate during production using this cell line, improving the chances of a match between vaccine and circulating influenza viruses.

"The NIH (National Institutes of Health) is interested in using this new cell line to make H3N2 human challenge strains since these recent H3N2 viruses do not grow well in existing cell lines," explains Kawaoka, professor of pathobiological sciences at the UW-Madison School of Veterinary Medicine. Human challenge trials help public health agencies identify the best vaccine virus candidates.

Kawaoka has already provided the cell line to public health agencies for testing influenza samples from patients and for testing the effectiveness of antiviral drugs against the circulating strains. He is also providing them to a UW-Madison graduate, Bharat Biotech CEO Krishna Ella, based in Hyderabad, India, for the company's work developing cell-based flu vaccines.

Kawaoka says the cell lines will be validated for vaccine use, and the Wisconsin Alumni Research Foundation has filed for a patent.

Flu vaccines work by arming the human immune system with the ability to recognize flu in the environment so that it can fight off infection. Viruses that mutate during vaccine production can lead to a less adequately prepared immune system. Limiting mutations in vaccine viruses is important for producing vaccines that work well.

While influenza viruses used for vaccines are usually grown in eggs, some are grown in specific cell lines such as MDCK (Madin-Darby canine kidney). But H3N2 is different: "H3N2 viruses -- the most important human viruses among the four strains circulating -- do not grow well in eggs or even in MDCK cells, which are most commonly used for influenza virus propagation," says Kawaoka. "H3N2 causes epidemics more often and causes more severe disease in humans."

Flu viruses infect cells by attaching to docking stations called receptors on the cell surface. Cells in birds, which also can be infected by flu viruses, and human lung cells each have the kinds of receptors that flu recognizes, though they are slightly different in each species and that can affect how well an influenza virus attaches to and makes copies of itself inside cells.

In 2005, Kawaoka's research group at the University of Tokyo, where he is also a professor of virology, modified MDCK cells to include more humanlike receptors. These cells, called AX4, better supported the growth of influenza. However, H3N2 viruses acquire mutations in these cells, too.

For the new study, Kawaoka's team modified MDCK cells by overexpressing human virus receptors and reducing avian virus receptors by using the gene-editing tool CRISPR-Cas9. They found that these cells, which they call hCK, better mimic those found in the human upper respiratory tract.

The researchers also learned that H3N2 viruses grow faster and in higher amounts in hCK cells compared to MDCK and AX4, and in the new cell line, the team could more reliably recover virus particles that came from patient samples.

"hCK cells are more than 100-fold better for growing human H3N2 viruses than AX4 cells," Kawaoka says.

Importantly, the H3N2 viruses were also far less likely to mutate in regions of the virus important to its function in vaccines.

"This finding is quite important in both public health and in vaccine production," Kawaoka says.
Doi: 10.1038/s41564-019-0433-6

The study was funded by the Japan Agency for Medical Research and Development (JP18am001007, JP18fm0108006, JP17jm0210042, JP18fk0108104); the Ministry of Education, Culture, Science, Sports, and Technology of Japan (16H06429,16K21723, 16H06434); the Japan Society for the Promotion of Science (17J04123) and the National Institute of Allergy and Infectious Disease (HHSN272201400008C).

--Kelly April Tyrrell,, 608-262-9772

CONTACT: Yoshihiro Kawaoka, or Kelly Tyrrell, 608-262-9772,


University of Wisconsin-Madison

Related Influenza Articles:

How proteins help influenza A bind and slice its way to cells
Researchers have provided new insight on how two proteins help influenza A virus particles fight their way to human cells.
Eating elderberries can help minimize influenza symptoms
Conducted by Professor Fariba Deghani, Dr. Golnoosh Torabian and Dr.
Mechanism to form influenza A virus discovered
A new study by Maria João Amorim's team, from the Gulbenkian Institute of Science, now reveals where the genomes of the influenza A virus are assembled inside infected cells.
Bat influenza viruses could infect humans
Bats don't only carry the deadly Ebola virus, but are also a reservoir for a new type of influenza virus.
New VaxArray publication on influenza neuraminidase quantification
InDevR Inc. announced publication of 'A Neuraminidase Potency Assay for Quantitative Assessment of Neuraminidase in Influenza Vaccines' in npj Vaccines.
Fighting mutant influenza
Another flu season is here, which means another chance for viruses to mutate.
Influenza vaccine delays are a problem for pediatricians
Uptake of influenza vaccine among children is low compared to other childhood vaccines, and missed opportunities for vaccination play an important role in this low uptake.
For a better influenza vaccine, focus on the neglected 'N'
In the April 5, 2018, issue of the journal Cell, researchers push for greater emphasis on the neglected viral-surface influenza protein neuraminidase.
Previous influenza virus exposures enhance susceptibility in another influenza pandemic
New data analysis suggests that people born at the time of the 1957 H2N2 or Asian Flu pandemic were at a higher risk of dying during the 2009 H1N1 Swine Flu pandemic as well as the resurgent H1N1 outbreak in 2013-2014.
Annual influenza vaccination does not prevent natural immunity
Earlier studies have suggested that having repeated annual influenza vaccination can prevent natural immunity to the virus, and potentially increase the susceptibility to influenza illness in the event of a pandemic, or when the vaccine does not 'match' the virus circulating in the community.
More Influenza News and Influenza Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

In & Out Of Love
We think of love as a mysterious, unknowable force. Something that happens to us. But what if we could control it? This hour, TED speakers on whether we can decide to fall in — and out of — love. Guests include writer Mandy Len Catron, biological anthropologist Helen Fisher, musician Dessa, One Love CEO Katie Hood, and psychologist Guy Winch.
Now Playing: Science for the People

#543 Give a Nerd a Gift
Yup, you guessed it... it's Science for the People's annual holiday episode that helps you figure out what sciency books and gifts to get that special nerd on your list. Or maybe you're looking to build up your reading list for the holiday break and a geeky Christmas sweater to wear to an upcoming party. Returning are pop-science power-readers John Dupuis and Joanne Manaster to dish on the best science books they read this past year. And Rachelle Saunders and Bethany Brookshire squee in delight over some truly delightful science-themed non-book objects for those whose bookshelves are already full. Since...
Now Playing: Radiolab

An Announcement from Radiolab